North Shore-Long Island Jewish Health System

Oncology & Cancer

Team studies obinutuzumab for treating chronic lymphocytic leukemia

Two North Shore-LIJ Cancer Institute doctors, world-renowned for their research in chronic lymphocytic leukemia (CLL), weigh in on a German study of a new drug therapy for CLL in the March 20 edition of the New England Journal ...

Oncology & Cancer

Inflammation in prostate may reduce cancer risk

Doctors at the North Shore-LIJ Health System have discovered that increased inflammation in the prostate may predict reduced risk for prostate cancer. The findings are published online in Cancer.

Oncology & Cancer

New 'Smart Rounds' improves safety of radiation therapy

The North Shore-LIJ Health System Department of Radiation Medicine has developed a novel process to optimize the safety and efficacy of radiation therapy and is presenting this data at the 55th Annual Meeting of in American ...

page 3 from 4